Farallon Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-500,000
| Closed | -$19.4M | – | 312 |
|
|
2021
Q2 | $19.4M | Hold |
500,000
| – | – | 0.08% | 101 |
|
|
2021
Q1 | $24.1M | Buy |
500,000
+400,000
| +400% | +$19.3M | 0.12% | 96 |
|
|
2020
Q4 | $5.2M | Buy |
+100,000
| New | +$5.2M | 0.03% | 120 |
|
|
2020
Q3 | – | Sell |
-1,500,000
| Closed | -$29.2M | – | 134 |
|
|
2020
Q2 | $29.2M | Buy |
+1,500,000
| New | +$29.2M | 0.23% | 74 |
|